Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases.
作者信息
Mertz Philippe, Chalayer Emilie, Amoura Zahir, Cathebras Pascal, Chiche Laurent, Coestedoat Nathalie, Deroux Alban, Diot Elisabeth, Durupt Stéphane, Forestier Emmanuel, Gorse Audrey, Hudier Laurent, Killian Martin, Lambotte Olivier, Lecomte Claire, Ledoult Emmanuel, Martinez Camille, Mathian Alexis, Morin Anne Sophie, Noel Nicolas, Pineton De Chambrun Marc, Terriou Louis, Sibilia Jean, Gottenberg Jacques-Eric, Korganow Anne-Sophie, Arnaud Laurent, Martin Thierry
机构信息
Service de Rhumatologie, Hôpitaux Universitaires de Strasbourg, Laboratoire d'ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, Centre National de Référence des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Université de Strasbourg, Strasbourg
Service de Médecine Interne et d'Immunologie Clinique, Hôpitaux Universitaires de Strasbourg, Centre National de Référence des Maladies Systémiques et Autoimmunes Rares Est Sud-Ouest (RESO), Université de Strasbourg, Strasbourg
出版信息
Haematologica. 2021 Mar 1;106(3):871-874. doi: 10.3324/haematol.2020.249896.
Abstract
摘要
相似文献
1
Clinical spectrum and therapeutic management of auto-immune myelofibrosis: a nation-wide study of 30 cases.自身免疫性骨髓纤维化的临床谱与治疗管理：一项30例的全国性研究。
Haematologica. 2021 Mar 1;106(3):871-874. doi: 10.3324/haematol.2020.249896.
2
Recent advances in the management of myelofibrosis.骨髓纤维化治疗的最新进展
Clin Adv Hematol Oncol. 2016 Aug;14(8):597-9.
3
Evaluation of survival risk scores in primary myelofibrosis: a Brazilian experience from a single institution.原发性骨髓纤维化生存风险评分的评估：来自巴西单一机构的经验
Leuk Lymphoma. 2008 Aug;49(8):1641-3. doi: 10.1080/10428190802141194.
4
Primary myelofibrosis and the myeloproliferative neoplasms: the role of individual variation.原发性骨髓纤维化和骨髓增生性肿瘤：个体差异的作用。
JAMA. 2010 Jun 23;303(24):2513-8. doi: 10.1001/jama.2010.853.
5
A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK.一项关于英国血液学学会骨髓纤维化诊断与管理指南在英国应用情况的医师调查。
Br J Haematol. 2020 Mar;188(6):e105-e109. doi: 10.1111/bjh.16390. Epub 2020 Feb 19.
6
Distinguishing autoimmune myelofibrosis from primary myelofibrosis.区分自身免疫性骨髓纤维化与原发性骨髓纤维化。
Clin Adv Hematol Oncol. 2018 Sep;16(9):619-626.
7
Myelofibrosis.骨髓纤维化
Hematology. 2014 Mar;19(2):120-1. doi: 10.1179/1024533213Z.000000000257.
8
Clinical and molecular genetic characterization of myelofibrosis.骨髓纤维化的临床与分子遗传学特征
Curr Opin Hematol. 2015 Mar;22(2):177-83. doi: 10.1097/MOH.0000000000000122.
9
Primary myelofibrosis: update on definition, pathogenesis, and treatment.原发性骨髓纤维化：定义、发病机制及治疗的最新进展
Annu Rev Med. 2009;60:233-45. doi: 10.1146/annurev.med.60.041707.160528.
10
Stem cell transplantation in primary myelofibrosis of childhood.儿童原发性骨髓纤维化中的干细胞移植
J Pediatr Hematol Oncol. 2013 Apr;35(3):e120-2. doi: 10.1097/MPH.0b013e31828800cc.
引用本文的文献
1
Systemic Lupus Erythematosus Presenting With Autoimmune Myelofibrosis in a Young Woman: A Case Report.一名年轻女性系统性红斑狼疮伴自身免疫性骨髓纤维化：病例报告
Clin Case Rep. 2025 Apr 18;13(4):e70362. doi: 10.1002/ccr3.70362. eCollection 2025 Apr.
2
When the mask slips: A peripheral T-cell lymphoma disguised as lupus with myelofibrosis in a patient with May-Hegglin syndrome.当面具滑落时：一名患有May-Hegglin综合征的患者中，一例伪装成狼疮并伴有骨髓纤维化的外周T细胞淋巴瘤。
Leuk Res Rep. 2024 Dec 20;23:100498. doi: 10.1016/j.lrr.2024.100498. eCollection 2025.
3
Autoimmune myelofibrosis: clinical and histological efficacy of ciclosporin treatment.自身免疫性骨髓纤维化：环孢素治疗的临床及组织学疗效
BMJ Case Rep. 2024 Jan 24;17(1):e256644. doi: 10.1136/bcr-2023-256644.
4
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity.小儿免疫性骨髓纤维化（PedIMF）是一种新型且独特的临床病理实体。
Front Pediatr. 2022 Nov 7;10:1031687. doi: 10.3389/fped.2022.1031687. eCollection 2022.
5
The Genetic Basis of Primary Myelofibrosis and Its Clinical Relevance.原发性骨髓纤维化的遗传学基础及其临床意义。
Int J Mol Sci. 2020 Nov 24;21(23):8885. doi: 10.3390/ijms21238885.
本文引用的文献
1
Distinguishing autoimmune myelofibrosis from primary myelofibrosis.区分自身免疫性骨髓纤维化与原发性骨髓纤维化。
Clin Adv Hematol Oncol. 2018 Sep;16(9):619-626.
2
Bone marrow fibrosis in myelofibrosis: pathogenesis, prognosis and targeted strategies.骨髓纤维化症中的骨髓纤维化：发病机制、预后及靶向治疗策略
Haematologica. 2016 Jun;101(6):660-71. doi: 10.3324/haematol.2015.141283.
3
Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature.自身免疫性骨髓纤维化：29例形态学特征的最新情况及文献综述
Hum Pathol. 2014 Nov;45(11):2183-91. doi: 10.1016/j.humpath.2014.07.017. Epub 2014 Aug 13.
4
Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns.骨髓纤维化中自身免疫现象的患病率增加：与临床和形态学特征的关系，以及与免疫调节细胞因子模式的关系。
Leuk Res. 2013 Nov;37(11):1509-15. doi: 10.1016/j.leukres.2013.09.001. Epub 2013 Sep 12.
5
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report.修订后的骨髓纤维化反应标准：国际工作组-骨髓增生性肿瘤研究和治疗（IWG-MRT）和欧洲白血病网络（ELN）共识报告。
Blood. 2013 Aug 22;122(8):1395-8. doi: 10.1182/blood-2013-03-488098. Epub 2013 Jul 9.
6
One thousand patients with primary myelofibrosis: the mayo clinic experience.一千例原发性骨髓纤维化患者：梅奥诊所的经验。
Mayo Clin Proc. 2012 Jan;87(1):25-33. doi: 10.1016/j.mayocp.2011.11.001.
7
Autoimmunity and the risk of myeloproliferative neoplasms.自身免疫与骨髓增殖性肿瘤风险。
Haematologica. 2010 Jul;95(7):1216-20. doi: 10.3324/haematol.2009.020412. Epub 2010 Jan 6.
8
Primary autoimmune myelofibrosis: definition of a distinct clinicopathologic syndrome.原发性自身免疫性骨髓纤维化：一种独特临床病理综合征的定义
Am J Hematol. 2003 Jan;72(1):8-12. doi: 10.1002/ajh.10258.
9
Range of antinuclear antibodies in "healthy" individuals.“健康”个体中抗核抗体的范围。
Arthritis Rheum. 1997 Sep;40(9):1601-11. doi: 10.1002/art.1780400909.
10
Autoimmune myelofibrosis. A steroid-responsive cause of bone marrow fibrosis associated with systemic lupus erythematosus.自身免疫性骨髓纤维化。一种与系统性红斑狼疮相关的骨髓纤维化的类固醇反应性病因。
Medicine (Baltimore). 1994 May;73(3):145-52.
Zotero 插件